TruScreen Group Ltd 2019 AR2
The report highlights TruScreen's significant commercial progress during the 2019 financial year, particularly in its primary market of China and expansion into Africa, Russia, and the Middle East. The company achieved a 132% increase in sales to NZ$1.86 million, driven by device installations and Single Use Sensor (SUS) pull-through. TruScreen also established a new pilot manufacturing facility in Australia to improve operating efficiencies and reduce costs. Additionally, the company received recognition from international organizations, including the World Health Organisation, for its point-of-care cervical cancer screening technology in low and middle-income countries.
Company: TruScreen Group Ltd
Sector: Manufacturing
Country: New Zealand
Year: 2019
Type: AR2
Pages: 58
Back to company
TruScreen Group Ltd
Annual Report
The report highlights TruScreen's significant commercial progress during the 2019 financial year, particularly in its primary market of China and expansion into Africa, Russia, and the Middle East. The company achieved a 132% increase in sales to NZ$1.86 million, driven by device installations and Single Use Sensor (SUS) pull-through. TruScreen also established a new pilot manufacturing facility in Australia to improve operating efficiencies and reduce costs. Additionally, the company received recognition from international organizations, including the World Health Organisation, for its point-of-care cervical cancer screening technology in low and middle-income countries.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2019
Reporting Period
Apr 1, 2018 - Mar 31, 2019
Fiscal Year
2019
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
No data available